|
Diabetes, Vol 36, Issue 8 959-962, Copyright © 1987 by American Diabetes Association
Insulin suppresses its own secretion in vivo
GM Argoud, DS Schade and RP Eaton
This study addressed the controversial question of whether a
negative-insulin-feedback loop exists in vivo. We utilized prehepatic
insulin production, calculated by computerized deconvolution analysis of
peripheral C-peptide concentration, as a measure of endogenous insulin
secretion. Prehepatic insulin production was determined in 10 normal men
who randomly underwent a control study and two additional studies involving
different insulin infusion rates that achieved circulating insulin
concentrations within the physiologic range during euglycemic clamps. The
results demonstrate a dose-dependent suppression of prehepatic insulin
production from 5.8 +/- 1.4 mU/min during the control study to 4.0 +/- 1.2
and 3.2 +/- 0.9 mU/min during plasma insulin levels of 34 +/- 4 and 61 +/-
6 microU/ml, respectively (P less than .05). Therefore, in contrast to
recently reported results in vitro, insulin inhibits its own secretion in
humans.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. M. Steil, K. Rebrin, C. Darwin, F. Hariri, and M. F. Saad
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
Diabetes,
December 1, 2006;
55(12):
3344 - 3350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Haugaard, O. Andersen, H. Storgaard, F. Dela, J. J. Holst, J. Iversen, J. O. Nielsen, and S. Madsbad
Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of {beta}-cells
Am J Physiol Endocrinol Metab,
October 1, 2004;
287(4):
E677 - E685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Riu, A. Mas, T. Ferre, A. Pujol, L. Gros, P. Otaegui, L. Montoliu, and F. Bosch
Counteraction of Type 1 Diabetic Alterations by Engineering Skeletal Muscle to Produce Insulin: Insights From Transgenic Mice
Diabetes,
March 1, 2002;
51(3):
704 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Khan, P. B. Goforth, M. Zhang, and L. S. Satin
Insulin Activates ATP-Sensitive K+ Channels in Pancreatic {beta}-Cells Through a Phosphatidylinositol 3-Kinase-Dependent Pathway
Diabetes,
October 1, 2001;
50(10):
2192 - 2198.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Aspinwall, J. R. T. Lakey, and R. T. Kennedy
Insulin-stimulated Insulin Secretion in Single Pancreatic Beta Cells
J. Biol. Chem.,
March 5, 1999;
274(10):
6360 - 6365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ahren, H. Larsson, and J. J. Holst
Effects of Glucagon-Like Peptide-1 on Islet Function and Insulin Sensitivity in Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
February 1, 1997;
82(2):
473 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Zawalich, G. J. Tesz, and K. C. Zawalich
Are 5-Hydroxytryptamine-preloaded beta -Cells an Appropriate Physiologic Model System for Establishing That Insulin Stimulates Insulin Secretion?
J. Biol. Chem.,
September 28, 2001;
276(40):
37120 - 37123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1987 by the American Diabetes Association.
|
|
| |
|